Biomaterials for enhancing anti-cancer immunity
Highlights•Biomaterials can potentially improve the safety and efficacy of cancer
immunotherapy.•Biomaterials scaffolds can program immune cell function in peripheral …
immunotherapy.•Biomaterials scaffolds can program immune cell function in peripheral …
[引用][C] Biomaterials for enhancing anti-cancer immunity
ST Koshy, DJ Mooney - Current Opinion in Biotechnology, 2016 - cir.nii.ac.jp
Biomaterials for enhancing anti-cancer immunity
ST Koshy, DJ Mooney - Current Opinion in Biotechnology, 2016 - infona.pl
Cancer immunotherapy is becoming a standard approach to treat many cancers. However,
shortcomings of current methods limit therapeutic benefit in many patients. Rationally …
shortcomings of current methods limit therapeutic benefit in many patients. Rationally …
Biomaterials for enhancing anti-cancer immunity
ST Koshy, DJ Mooney - Current opinion in biotechnology, 2016 - pubmed.ncbi.nlm.nih.gov
Cancer immunotherapy is becoming a standard approach to treat many cancers. However,
shortcomings of current methods limit therapeutic benefit in many patients. Rationally …
shortcomings of current methods limit therapeutic benefit in many patients. Rationally …
Biomaterials for enhancing anti-cancer immunity.
ST Koshy, DJ Mooney - Current Opinion in Biotechnology, 2016 - europepmc.org
Cancer immunotherapy is becoming a standard approach to treat many cancers. However,
shortcomings of current methods limit therapeutic benefit in many patients. Rationally …
shortcomings of current methods limit therapeutic benefit in many patients. Rationally …
[HTML][HTML] Biomaterials for enhancing anti-cancer immunity
ST Koshy, DJ Mooney - Current opinion in biotechnology, 2016 - ncbi.nlm.nih.gov
Cancer immunotherapy is becoming a standard approach to treat many cancers. However,
shortcomings of current methods limit therapeutic benefit in many patients. Rationally …
shortcomings of current methods limit therapeutic benefit in many patients. Rationally …
Biomaterials for enhancing anti-cancer immunity.
ST Koshy, DJ Mooney - Current Opinion in Biotechnology, 2016 - europepmc.org
Cancer immunotherapy is becoming a standard approach to treat many cancers. However,
shortcomings of current methods limit therapeutic benefit in many patients. Rationally …
shortcomings of current methods limit therapeutic benefit in many patients. Rationally …